期刊文献+

Hospital without dyspnea: rationale and design of a multidisciplinary intervention

Hospital without dyspnea: rationale and design of a multidisciplinary intervention
下载PDF
导出
摘要 Dyspnea is a common and disabling symptom of respiratory and heart diseases, which is growing in incidence. During hospital admis- sion, breathlessness is under-diagnosed and under-treated, although there are treatments available for controlling the symptom. We have developed a tailored implementation strategy directed to medical staff to promote the application of these pharmacological and non-pharmacological tools in dealing with dyspnea. The primary aim is to decrease the rate of patients that do not receive an adequate relief of dyspnea. This is a four-stage quasi-experimental study. The intervention consists in two teaching talks that will be taught in Cardiology and Respiratory Medicine Departments. The contents will be prepared by Palliative Care specialists, based on available tools for management of dyspnea and patients' needs. A cross-sectional study of dyspnea in hospitalized patients will be performed before and after the intervention to ascertain an improvement in dyspnea intensity due to changes in medical practices. The last phase consists in the creation of consensus protocols for dyspnea management based in our experience. The results of this study are expected to be of great value and may change clinical practice in the near future and promote a changing for the better of dyspnea care.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2016年第7期625-631,共7页 老年心脏病学杂志(英文版)
关键词 Chronic pulmonary disease DYSPNEA Heart failure Palliative care 长期的肺的疾病;呼吸困难;心失败;辩解的照顾
  • 相关文献

参考文献35

  • 1Simon ST, Higginson I J, Benalia H, et al. Episodes of breath- lessness: types and pattems--a qualitative study exploring experiences of patients with advanced diseases. Palliat Med 2013; 27: 524-532.
  • 2Parikh RB, Kirch RA, Smith TJ, Temel JS. Early specialty palliative care--translating data in oncology into practice. N EnglJMed2013; 369:2347- 2351.
  • 3Mahler DA, O'Donnell DE. Recent advances in dyspnea. Chest 2015; 147: 232-241.
  • 4Johnson MJ, Abemethy AP, Currow DC. Gaps in the evi- dence base of opioids for refractory breathlessness. A future work plan? JPain Symptom Manage 2012; 43: 614-624.
  • 5Hui D, Morgado M, Vidal M, et al. Dyspnea in hospitalized advanced cancer patients: subjective and physiologic corre- lates. JPalliat Med 2013; 16: 274-280.
  • 6Currow DC1, Abemethy AP. Pharmacological management of dyspnoea. Curr Opin Support Palliat Care 2007; 1: 96-101.
  • 7Moens K, Higginson I J, Harding R. Are there differences in the prevalence of palliative-care related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manage 2014; 48: 66Oq577.
  • 8Viola R, Kiteley C, Lloyd NS, et al. The management of dyspnea in cancer patiets: a systematic review. Support Care Cancer 2008; 16: 329-337.
  • 9Currow DC, Abernethy AP, Ko DN. The active identification and management of chronic refractory breathlessness is a hu- man right. Thorax 2014; 69: 393-394.
  • 10Johnson MJ, Abemethy AP, Currow DC. The evidence base for oxygen for chronic refractory breathlessness: issues, gaps and a future work plan. J Pain Symptom Manage 2013; 45: 763-775.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部